Navigate to Other Sector


Healthcare Newsletter – May 2018

Takeda announces the Deal on much Coveted Shire for USD 62 Billion
Perpetuating Indian interest in Specialty Pharma
Evolving Pricing Dynamics &Competitive Landscape in Indian Med Tech industry
WHO’s Essential Diagnostics List emphasizes criticality of Expanding Access beyond Drugs
Novel Drug Approval Round-up – Auto-injector for migraine & Opioid management

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons